Skip to content


Azactam, Cayston (aztreonam) is a small molecule pharmaceutical. Aztreonam was first approved as Azactam on 1986-12-31. It is used to treat bacterial infections, cellulitis, endometritis, intraabdominal infections, and pseudomonas infections amongst others in the USA. It has been approved in Europe to treat cystic fibrosis and respiratory tract infections. Aztreonam's patent is valid until 2021-12-20 (FDA).
Trade Name Cayston
Common Name Aztreonam
Indication bacterial infections, cellulitis, cystic fibrosis, endometritis, intraabdominal infections, pseudomonas infections, respiratory tract infections, urinary tract infections
Drug Class
Get full access now